HFHekma Saad Farghaly

Hekma Saad Farghaly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hekma Saad Farghaly has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aromatase excess syndrome in children: insight on pathophysiology, clinical manifestation, and management

    by Kotb Abbass Metwalley, Hekma Saad Farghaly

    Aromatase Excess Syndrome (AEXS) a rare autosomal dominant genetic and endocrinal condition is characterized by excess conversion of androgens to estrogens, primarily due to increased aromatase enzyme activity. It is most often caused by genetic involving the CYP19A1 gene, which encodes aromatase enzyme. It is characterized by pre or peri-pubertal gynecomastia. Other features of AEXS include accelerated bone age, short final height, symptoms of testosterone insufficiency in males, with early puberty and macromastia in females. The majority of AEXS patients had high serum levels of estradiol and estrone. Confirming the diagnosis of AEXS requires molecular analysis of CYP19A1 variants. Long-term usage of aromatase inhibitors (AIs) with or without surgical mastectomy is part of the treatment for children with AEXS. This article provides endocrinologists with a narrative overview of the epidemiology, genetics, pathogenesis, clinical picture, diagnostic procedures, and current approaches of management of AEXS in children.

  • Open Access

    Overview of Endocrine Dysfunction in Children with Turner Syndrome

    by Kotb Abbass Metwalley, Hekma Saad Farghaly

    Turner syndrome (TS) is a common, non-heritable genetic condition affecting ~1 in 2000 females and is brought on by complete or partial absence of the second sex chromosome. Neurocognitive impairments and a variety of conditions, including endocrinopathies, renal abnormalities, lymphedema, congenital heart disease, and celiac disease, are linked to TS. Compared to the general population, TS patients have far higher rates of endocrine illnesses, including short stature, ovarian insufficiency, autoimmune thyroid diseases, glucose dyshomeostasis, obesity, bone abnormalities, androgen deficiency, gonadoblastoma, and adrenal tumors. This review provides endocrinologists with a narrative overview of the clinical picture, diagnostic procedures, and current approaches to the management of the endocrine abnormalities that affect children with TS.

  • Refractory hypothyroidism in children: an overview

    by Kotb Abbass Metwalley, Hekma Saad Farghaly

    Refractory hypothyroidism (RF) defined as raised serum levels of thyroid stimulating hormone (TSH) above upper limit of the reference range with or without the persistence of hypothyroid symptoms following a 6-week interval after the dosage was last increased to upper limits of dose per age. The most common cause of RH is inadequate compliance. In addition, diet, concomitant medication interactions, and gastrointestinal diseases can all result in l -thyroxine (LT4) malabsorption, which can cause RH. Moreover, weight gain, switching brands of LT4, poor storage of LT4, chronic liver disorders, cystic fibrosis, nephrotic syndrome, consumptive hypothyroidism, Addison’s disease are significant contributors to RF in children. RH in children is frequently asymptomatic, when symptoms do occur, they are typically minor and resemble those of hypothyroidism. It is essential to identify RH early and treat its underlying cause in order to avoid overusing LT4, which can lead to cardiac and bone problems. Endocrinologists should handle children who they suspect of having RH methodically after making sure there is enough compliance. Searching for undiagnosed illnesses and/or other factors that can affect LT4 absorption could be part of this. We present this review after an extensive literature search and long-standing clinical experience. This review’s objective is to shed light on the causes, clinical manifestations, investigations, and treatment of RH in children.


  • Open Access

    Idiopathic ketotic hypoglycemia in children: an update

    by Kotb Abbass Metwalley, Hekma Saad Farghaly

    Idiopathic ketotic hypoglycemia (IKH) is defined as bouts of hypoglycemia with increased blood or urine ketones in certain children after prolonged fasting or during illness. IKH is divided into physiological IKH, which is most frequently observed in normal children with intercurrent acute illness, and pathological IKH, which occurs in children who lack counter-regulatory hormones, have a metabolic disease, or have Silver-Russell syndrome. The typical patient is a young child between the ages of 10 months and 6 years. Episodes nearly always occur in the morning after overnight fasting. Symptoms include those of neuroglycopenia, ketosis, or both. IKH may be diagnosed after ruling out various metabolic and hormonal conditions associated with ketotic hypoglycemia. Sufficient amounts of carbohydrates and protein, avoidance of prolonged fasting, and increased frequency of food ingestion are the main modes of treating IKH. It is crucial to understand the pathogenesis of IKH and to distinguish physiological IKH from pathological IKH. In this mini-review, we present a brief summary of IKH in terms of its definition, types, clinical presentation, diagnosis, and therapeutic approach in children.


  • Open Access

    Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment

    by Kotb Abbass Metwalley, Hekma Saad Farghaly

    Gynecomastia (GM) is a common and continuously evolving condition that commonly occurs during adolescence. It is the source of significant embarrassment and psychological stress in adolescent males. GM is characterized by enlargement of the male breast due to the proliferation of glandular ducts and stromal components. The main cause of GM during adolescence is physiological or pubertal GM, which is primarily attributed to an imbalance between estrogen and androgen activity. Physiological GM is typically transient and resolves within several months, although it may take several years to resolve. GM may also be caused by other pathological conditions and could be indicative of an endocrine disease. It is crucial to understand the pathogenesis of GM to distinguish it from normal developmental variants due to pathological causes. The aim of this review is to highlight the significance of GM during adolescence in terms of potential etiologies, clinical and laboratory diagnoses, and current management.


  • Open Access

    Ovarian reserve in adolescent girls with autoimmune thyroiditis

    by Kotb A. Metwalley, Hekma S. Farghaly, Deiaaeldin M. Tamer, Ahmed M. Ali, Mostafa Embaby, Islam F. Elnakeeb, Eman B. Kamaleldeen

    Objectives: To assess serum anti-Müllerian hormone (AMH) levels as an ovarian reserve marker in adolescent girls with autoimmune thyroiditis (AIT) and explore the relationship of this marker with autoimmunity and thyroid function biomarkers. Subjects and methods: This study included 96 adolescent girls with newly diagnosed AIT and 96 healthy, age- and sex-matched controls. All participants were evaluated with detailed history taking and physical examination, thyroid ultrasound, and measurement of levels of thyroid-stimulating hormone (TSH), free thyroxin (FT4), free triiodothyronine [...] ABSTRACT Objectives: To assess serum anti-Müllerian hormone (AMH) levels as an ovarian reserve marker in adolescent girls with autoimmune thyroiditis (AIT) and explore the relationship of this marker with autoimmunity and thyroid function biomarkers. Subjects and methods: This study included 96 adolescent girls with newly diagnosed AIT and 96 healthy, age- and sex-matched controls. All participants were evaluated with detailed history taking and physical examination, thyroid ultrasound, and measurement of levels of thyroid-stimulating hormone (TSH), free thyroxin (FT4), free triiodothyronine


  • Open Access

    Endocrinal dysfunction in children with Down syndrome

    by Kotb Abbass Metwalley, Hekma Saad Farghaly

    Down syndrome (DS) is the most common genetic disorder in live-born infants. Children with DS are at increased risk of numerous endocrinal comorbidities. The information contained in this article will provide pediatricians with a narrative overview of different presentations, diagnoses, and management recommendations of various endocrinal disorders in children with DS. We systematically searched PubMed, Embase, Google Scholar, MEDLINE, EBSCO, and Science Direct, and potentially relevant articles were identified and retrieved from electronic and print journals.


  • Open Access

    Vestibular function for children with insulin dependent diabetes using cervical vestibular evoked myogenic potentials testing

    by Sherifa Ahmed Hamed, Kotb Abbas Metwalley, Hekma Saad Farghaly, Amira Mohamed Oseily

    Vestibular function for children with insulin dependent diabetes using cervical vestibular evoked myogenic potentials testing


  • Open Access

    Hormone resistance in children: what primary care physicians need to know

    by Kotb Abbass Metwalley, Hekma Saad Farghaly

    Hormone resistance is defined as a reduced or absence of target tissues responsiveness to a hormone, where the presentation is related to either a relative lack or excess of hormones. Various disorders of hormone resistance were encountered including, Laron syndrome, nephrogenic diabetes insipidus, thyroid hormone resistance syndrome, pseudohypoparathyroidism, insulin resistance, familial glucocorticoid deficiency, pseudohypoaldosteronism, X linked hypophosphatemic rickets and androgen insensitivity syndrome. The article gives a summary that presents, in concentrated form, what the primary care physicians need to know about recognition, clinical presentation, diagnosis, and management of various hormone resistance in children.


  • Open Access

    Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus

    by Kotb Abbass Metwalley, Hekma Saad Farghaly, Magda Farghali Gabri, Safwat Mohamed Abdel-Aziz, Asmaa Mohamed Ismail, Duaa Mohamed Raafat, Islam Fathy Elnakeeb

    This study was aimed to assess the role of serum midkine (MK) as a biomarker for early detection of diabetic nephropathy (DN) in children with type 1 diabetes mellitus (T1DM) before microalbuminuria emerges. A total of 120 children with T1DM, comprising 60 microalbuminuric patients ( group 1), 60 normoalbuminuric patients ( group 2), and 60 healthy participants as a control group ( group 3) were included in this study. Detailed medical history, clinical examination, and laboratory assessment of high-sensitivity C-reactive protein (hs- CRP) , hemoglobin A1c% (HbA1c%) , lipid profile , urinary albumin creatinine ratio (ACR), serum MK, and estimated glomerular filtration rate based on serum creatinine (eGFR-Cr) were performed in the three studied group. Our study revealed significantly higher serum MK in both diabetic groups compared to controls (p < 0.001). Additionally, patients with microalbuminuria had higher serum MK concentrations than those with normoalbuminuria (p<0.001). The normoalbuminuric group had highly significantly elevated serum MK compared with the control group (p < 0.001). Receiver operating characteristic (ROC) curve analysis revealed that MK cutoff value of 1512 pg/ml was able to predict microalbuminuria with a sensitivity of 96% and specificity of 92%. Stepwise regression analysis revealed that HbA1c %, hs- CRP, and urinary ACR were independently related to MK levels (p < 0.001 for each). The results of this study suggest that serum MK is a useful, novel, practical marker for the evaluation of renal involvement in children with T1DM, especially in normoalbuminuric children.